Spyre Therapeutics, Inc. (SYRE)
Nasdaq: SYRE · CIK 0001636282 · United States
Every official Spyre Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open SYRE filings
Spyre Therapeutics, Inc. documents
- Spyre Therapeutics, Inc. 10-K 2026SYRE 10-K 2026: annual report for fiscal 2026
- Spyre Therapeutics, Inc. 10-K 2025SYRE 10-K 2025: annual report for fiscal 2025
- Spyre Therapeutics, Inc. 10-K 2024SYRE 10-K 2024: annual report for fiscal 2024
- Spyre Therapeutics, Inc. 10-K 2023SYRE 10-K 2023: annual report for fiscal 2023
- Spyre Therapeutics, Inc. 10-K 2022SYRE 10-K 2022: annual report for fiscal 2022
- Spyre Therapeutics, Inc. 10-Q 2026SYRE 10-Q 2026: quarterly report for fiscal 2026
- Spyre Therapeutics, Inc. 10-Q 2025SYRE 10-Q 2025: quarterly report for fiscal 2025
- Spyre Therapeutics, Inc. 10-Q 2024SYRE 10-Q 2024: quarterly report for fiscal 2024
- Spyre Therapeutics, Inc. 10-Q 2023SYRE 10-Q 2023: quarterly report for fiscal 2023
- Spyre Therapeutics, Inc. 10-Q 2022SYRE 10-Q 2022: quarterly report for fiscal 2022
- Spyre Therapeutics, Inc. 8-K 2026SYRE 8-K 2026: current report for fiscal 2026
- Spyre Therapeutics, Inc. 8-K 2025SYRE 8-K 2025: current report for fiscal 2025
- Spyre Therapeutics, Inc. 8-K 2024SYRE 8-K 2024: current report for fiscal 2024
- Spyre Therapeutics, Inc. 8-K 2023SYRE 8-K 2023: current report for fiscal 2023
- Spyre Therapeutics, Inc. 8-K 2022SYRE 8-K 2022: current report for fiscal 2022
- Spyre Therapeutics, Inc. DEF 14A 2026SYRE DEF 14A 2026: proxy statement for fiscal 2026
- Spyre Therapeutics, Inc. DEF 14A 2025SYRE DEF 14A 2025: proxy statement for fiscal 2025
- Spyre Therapeutics, Inc. DEF 14A 2024SYRE DEF 14A 2024: proxy statement for fiscal 2024
- Spyre Therapeutics, Inc. DEF 14A 2023SYRE DEF 14A 2023: proxy statement for fiscal 2023
- Spyre Therapeutics, Inc. DEF 14A 2022SYRE DEF 14A 2022: proxy statement for fiscal 2022
- Spyre Therapeutics, Inc. Form 4 2026SYRE Form 4 2026: insider trading filing for fiscal 2026
- Spyre Therapeutics, Inc. Form 4 2025SYRE Form 4 2025: insider trading filing for fiscal 2025
- Spyre Therapeutics, Inc. Form 4 2024SYRE Form 4 2024: insider trading filing for fiscal 2024
- Spyre Therapeutics, Inc. Form 4 2023SYRE Form 4 2023: insider trading filing for fiscal 2023
- Spyre Therapeutics, Inc. Form 4 2022SYRE Form 4 2022: insider trading filing for fiscal 2022
- Spyre Therapeutics, Inc. S-1 2026SYRE S-1 2026: registration statement for fiscal 2026
- Spyre Therapeutics, Inc. S-1 2025SYRE S-1 2025: registration statement for fiscal 2025
- Spyre Therapeutics, Inc. S-1 2024SYRE S-1 2024: registration statement for fiscal 2024
- Spyre Therapeutics, Inc. S-1 2023SYRE S-1 2023: registration statement for fiscal 2023
- Spyre Therapeutics, Inc. S-1 2022SYRE S-1 2022: registration statement for fiscal 2022
- Spyre Therapeutics, Inc. 13F 2026SYRE 13F 2026: institutional holdings for fiscal 2026
- Spyre Therapeutics, Inc. 13F 2025SYRE 13F 2025: institutional holdings for fiscal 2025
- Spyre Therapeutics, Inc. 13F 2024SYRE 13F 2024: institutional holdings for fiscal 2024
- Spyre Therapeutics, Inc. 13F 2023SYRE 13F 2023: institutional holdings for fiscal 2023
- Spyre Therapeutics, Inc. 13F 2022SYRE 13F 2022: institutional holdings for fiscal 2022
More companies